Universal Health Services, Inc. owns and operates acute care hospitals and outpatient and behavioral health care facilities in the United States through its subsidiaries. It operates through two segments: Acute Care Hospital Services and Behavioral Health Care Services. Its hospitals provide general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric, pharmacy, and/or behavioral health services. The company also offers commercial health insurance services, capital resources, and various management services, including central purchasing, information services, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations. Founded in 1978, it is headquartered in King of Prussia, Pennsylvania.
UHS swings on AI upside, labor shortages, and mixed earnings
▲
AI coding platform adds $50M annualized revenue UBS says hospitals may gain more from AI than insurers, noting UHS already earns about $50 million a year from an AI coding platform. This supports profit margins and gives UHS a multiyear edge over slower nonprofit rivals, pushing the stock up.
Shows a new, concrete technology-driven revenue and margin driver for UHS.
▼
Nursing shortage worsens, raising labor costs The nursing shortage rate jumped from 28% to 39%, and peer HCA cut its profit outlook. For UHS, this means higher wages and tighter margins, a real headwind that pushed shares down 5.6% on the day and keeps pressure on the stock.
Identifies a key supply-side cost pressure that directly hurts UHS profitability.
◆
Q2 profit rises but guidance cut on higher costs UHS reported higher Q2 net income of $358.4 million and 8.3% revenue growth, but then cut full-year EPS guidance and missed Q2 expectations as operating expenses rose 9%. The strong quarter is offset by cost worries, leaving the stock down on the guidance cut.
Captures the latest earnings result and the guidance cut that moved the stock.
Q3 2026
▲1▼1
UHS swings on AI upside, labor shortages, and mixed earnings
▲
AI coding platform adds $50M annualized revenue UBS says hospitals may gain more from AI than insurers, noting UHS already earns about $50 million a year from an AI coding platform. This supports profit margins and gives UHS a multiyear edge over slower nonprofit rivals, pushing the stock up.
Shows a new, concrete technology-driven revenue and margin driver for UHS.
▼
Nursing shortage worsens, raising labor costs The nursing shortage rate jumped from 28% to 39%, and peer HCA cut its profit outlook. For UHS, this means higher wages and tighter margins, a real headwind that pushed shares down 5.6% on the day and keeps pressure on the stock.
Identifies a key supply-side cost pressure that directly hurts UHS profitability.
◆
Q2 profit rises but guidance cut on higher costs UHS reported higher Q2 net income of $358.4 million and 8.3% revenue growth, but then cut full-year EPS guidance and missed Q2 expectations as operating expenses rose 9%. The strong quarter is offset by cost worries, leaving the stock down on the guidance cut.
Captures the latest earnings result and the guidance cut that moved the stock.
News & notes movingUHS
United States
UHS▲
Universal Health Services Beats Q2 Estimates, Raises Revenue Guidance
Universal Health Services reported second-quarter 2026 adjusted earnings per share of $5.98, beating the Zacks Consensus Estimate by 5.7% and rising 10.1% year over year, while net revenues of $4.6 billion improved 8.3% and topped estimates by 2.6%. The company raised its full-year net revenue guidance to $18.501-$18.762 billion from $18.417-$18.789 billion, but lowered its adjusted EBITDA forecast to $2.610-$2.717 billion and adjusted EPS outlook to $22.28-$23.65. During the quarter, Universal Health repurchased shares worth approximately $320.3 million, leaving about $977.6 million under its buyback program. Shares have gained 5.7% since the earnings report, outperforming the S&P 500, though the consensus estimate has shifted down 5.42% over the past month. The stock carries a Zacks Rank #3 (Hold).
Universal Health Services completes $835 million Talkspace acquisition
Universal Health Services has completed its acquisition of virtual behavioral healthcare provider Talkspace in an all-cash transaction valued at approximately $835 million, or $5.25 per share, funded with borrowings under UHS' existing revolving credit facility. Talkspace brings roughly 6,000 licensed therapists and psychiatrists to UHS, along with access to more than 200 million individuals through health plans, employers and other channels. The deal adds a digital layer to UHS' facility-based behavioral health operations, with Talkspace's online therapy and psychiatry offerings complementing in-person care and enabling patient referrals between the two companies. UHS expects the transaction to be slightly accretive to adjusted EPS within the first 12 months, excluding one-time acquisition costs, with greater accretion thereafter, and sees the effective EBITDA multiple reaching the single-digit range by the third year. In the second quarter of 2026, UHS' behavioral health same-facility revenues rose 7.4% year over year, while revenue per adjusted admission increased 7.1%.
Universal Health Services Completes Buyback and Posts Q2 2026 Earnings
Universal Health Services has completed its long-running share repurchase program and released second quarter 2026 earnings, drawing fresh investor attention. The stock recently traded at $167.87, down 23.65% year to date despite a 1-year total shareholder return of 2.36%. A widely followed narrative pegs the company's fair value at $205.24, suggesting it is 18.2% undervalued, based on assumptions of revenue growth from outpatient behavioral health expansion and a leaner share count. However, risks remain from potential Medicaid policy changes and persistent workforce shortages that could pressure margins.
Eight of nine healthcare companies beat EPS estimates this week
Eight out of nine healthcare companies that reported quarterly results this week beat earnings-per-share expectations, while all nine exceeded revenue consensus. Centene posted second-quarter revenue of $53.6 billion, topping estimates by $6.1 billion, and raised its full-year revenue guidance to $193.5 billion to $197.5 billion. Boston Scientific reported revenue of $5.4 billion, beating by $70 million, but lowered its full-year net sales growth outlook to 5.5% to 6.5% year-over-year. DexCom beat on both top and bottom lines and raised the midpoint of its 2026 revenue guidance to a range of $5.18 billion to $5.25 billion. Universal Health Services was the only company to miss EPS estimates.
Universal Health Services beats Q2 earnings and revenue estimates
Universal Health Services reported second-quarter 2026 adjusted earnings per share of $5.98, beating the Zacks Consensus Estimate by 5.7% and rising 10.1% year over year. Net revenues of $4.6 billion improved 8.3% year over year and surpassed the consensus mark by 2.6%, driven by healthy revenue growth across both the Acute Care and Behavioral Health segments. Adjusted EBITDA, net of NCI, rose 5.4% to $677.9 million, while total operating costs escalated 8.9% to $4.1 billion due to higher salaries, supplies, and other expenses. The company updated its full-year 2026 guidance, now expecting net revenues of $18.501 billion to $18.762 billion, adjusted EBITDA of $2.610 billion to $2.717 billion, and adjusted EPS of $22.28 to $23.65. Universal Health also repurchased shares worth approximately $320.3 million during the quarter, with around $977.6 million remaining under its authorization.
Coca-Cola, Sherwin-Williams lead premarket gainers on earnings beats
Coca-Cola and Sherwin-Williams were among the biggest premarket movers after both companies reported quarterly results that exceeded expectations and raised their full-year outlooks. Coca-Cola shares rose 2% after posting adjusted earnings of 97 cents per share on revenue of $13.38 billion, topping analyst estimates. Sherwin-Williams climbed nearly 6% with adjusted earnings of $3.70 per share on $6.79 billion in revenue, also beating forecasts and lifting its full-year earnings guidance. Johnson & Johnson gained more than 2% after agreeing to pay $5.5 billion to settle talc-related ovarian cancer lawsuits. Hilton Worldwide fell 2.7% after issuing third-quarter earnings guidance below consensus, while Universal Health Services dropped 3% on a lowered full-year outlook. Welltower advanced 4.5% after raising its full-year normalized funds from operations forecast above estimates, and Happen, formerly LendingClub, surged more than 6% on stronger-than-expected full-year earnings guidance.
Applied Digital, Celestica, and OPKO Health surge on strong earnings and raised outlooks
Applied Digital, Celestica, and OPKO Health were among Tuesday's biggest stock gainers after each reported quarterly results that beat expectations and raised their forward guidance. Applied Digital shares rose 4% as the AI infrastructure company posted a 407% year-over-year revenue surge to $258.7 million and adjusted earnings of $0.04 per share, driven by the on-time deployment of 175 megawatts of AI capacity at its Polaris Forge campus. Celestica gained 4% after revenue jumped 62% to $4.7 billion and adjusted EPS of $2.54 topped estimates, prompting the electronics manufacturer to lift its full-year 2026 revenue forecast to $20.5 billion and adjusted EPS outlook to $11.30, with management citing strong AI infrastructure demand and expecting 2027 revenue growth to accelerate further. OPKO Health climbed 9% as the company beat second-quarter revenue and earnings estimates, raised its full-year 2026 revenue guidance to a range of $560 million to $585 million, and narrowed its net loss to $0.01 per share, supported by a roughly 60% increase in pharmaceutical revenue that included $33.6 million in royalties and milestone payments. On the losing side, Aehr Test Systems fell 5% after filing a mixed shelf registration that investors viewed as a potential source of future dilution, while Universal Health Services slipped 4% after cutting its full-year 2026 non-GAAP EPS guidance to a range of $22.28 to $23.65 and reporting second-quarter earnings below expectations amid a 9% rise in operating expenses to $4.1 billion.
Cadence Design, Rambus, Welltower lead after-hours stock moves on earnings beats and guidance raises
Several companies made notable after-hours moves following their latest earnings reports. Cadence Design Systems rose more than 4% after posting second-quarter adjusted earnings of $2.11 per share, beating the LSEG consensus of $2.05, while revenue of $1.58 billion met expectations. Rambus edged higher after reporting adjusted earnings of 77 cents per share on revenue of $207 million, exceeding analyst estimates of 72 cents and $198 million. Welltower jumped 4% after the senior housing real estate investment trust raised its full-year normalized funds from operations guidance to a range of $6.36 to $6.44 per share, above the FactSet consensus of $6.30. Universal Health Services dropped more than 4% after lowering its full-year adjusted earnings guidance to between $22.28 and $23.65 per share, down from a prior range of $22.64 to $24.52. Happen, the bank formerly known as LendingClub, advanced 4% after issuing full-year earnings guidance of $1.80 to $1.90 per share, surpassing the FactSet consensus of $1.74, and projecting loan originations of $12.2 billion to $12.6 billion. F5 gained nearly 2% after third-quarter adjusted earnings of $4.73 per share on revenue of $865 million topped the LSEG consensus of $4 per share and $388 million. Cincinnati Financial lost almost 4% after operating earnings of $1.43 per share missed the FactSet consensus of $1.84, and net premiums of $2.64 billion came in slightly below the expected $2.66 billion. Nucor dipped 1% despite beating second-quarter earnings and revenue expectations, with the stock already up more than 50% year to date. Principal Financial Group fell 3% even though operating earnings of $2.42 per share exceeded the FactSet consensus of $2.34, as the stock had already risen more than 25% this year.
Welltower, Universal Health, Element Solutions move sharply after earnings
Welltower, Universal Health Services, and Element Solutions made notable after-hours moves on Tuesday following their quarterly earnings reports. Welltower advanced more than 4% after the bell, recovering from a nearly 1.5% decline during the regular session, after the healthcare REIT beat second-quarter earnings estimates and raised its 2026 guidance. Universal Health Services dropped about 10.4% in extended trading despite a 2.3% gain at the close, as its revenue rose 8.4% year-over-year but earnings per share missed expectations by $0.03. Element Solutions added to its 1.1% regular-session gain after reporting an EPS and revenue beat.
Universal Health Services shares fall 5.6% amid nursing shortage and HCA profit warning
Shares of Universal Health Services fell 5.6% to close at $144.23 after a reported surge in nursing shortages and a profit forecast cut by peer HCA Healthcare pressured the hospital sector. The nursing shortage rate reportedly jumped from 28% to 39%, raising expectations of higher labor costs and tighter margins. HCA, the largest for-profit U.S. hospital operator, lowered its profit outlook due to an increase in uninsured patients following losses in Obamacare coverage. Universal Health Services stock is down 34.6% year-to-date and trades 41.1% below its 52-week high of $244.18 from November 2025.
UHS · Supply · Negative Nursing shortage rate surged from 28% to 39%, raising expectations of higher labor costs and tighter margins for Universal Health Services.
HCA · Demand · Negative HCA lowered profit outlook due to increase in uninsured patients after Obamacare coverage losses, indicating weaker demand for hospital services.
Universal Health Services and GW Medical Faculty Associates Announce Physician-Led Care Agreement
Universal Health Services, the George Washington University, and Medical Faculty Associates announced an agreement to transition clinical services to a newly created provider group while continuing medical education at GW Hospital. The agreement covers GW Hospital, Cedar Hill Regional Medical Center, and affiliated outpatient sites. A UHS affiliate will establish Capital Medical Group, a physician-led not-for-profit practice group, and UHS will become financially responsible for physician practice operations after the transition period.
Universal Health Services stock screens as undervalued despite Medicare payment boost
Universal Health Services shares appear undervalued on valuation metrics, passing all six checks in a framework analysis, even after a recent price lift from a proposed 2.4% Medicare payment increase. The stock trades at a price-to-earnings ratio of 6.3 times, far below the healthcare industry average of about 25.9 times and a peer group average near 21.0 times. A tailored fair P/E estimate of 19.9 times suggests the market is pricing the company well below what fundamentals might justify. Despite recent optimism around expected second-quarter 2026 earnings and the share price lift on the proposed 2.4% Medicare payment increase, the P/E still sits far under both the modelled fair ratio and sector benchmarks. The key question remains whether earnings and reimbursements hold up enough for that discount to narrow, or if policy and behavioral health risks mean the current pricing is closer to fair.
TD Cowen cuts Universal Health Services price target to $197, keeps Buy rating
TD Cowen lowered its price target on Universal Health Services from $230 to $197 while maintaining a Buy rating, implying a 24% upside from current levels. The revision follows a May hospital survey showing flat year-over-year revenue, leading the firm to reduce growth expectations for 2026 and 2027, with weaker surgical volumes partly offset by other medical services. Universal Health Services operates acute care hospitals, behavioral health facilities, and outpatient centers across the US, Puerto Rico, and the UK.
StockStory: Netflix a Buy, Deckers and Universal Health Services to Avoid
StockStory recommends buying Netflix while advising investors to sell Deckers and Universal Health Services. Netflix stands out with 15.6% annual growth in global streaming paid memberships over two years, 49.2% annual EPS growth over three years, and a free cash flow margin that expanded by 16.2 percentage points. Deckers is flagged for underwhelming constant currency revenue, an operating margin of 23.4% below the industry average, and a projected 5.1 percentage point decline in free cash flow margin next year. Universal Health Services is seen as having weak comparable store sales trends and lacking free cash flow generation.
DECK · Capital · Negative StockStory recommends selling Deckers due to underwhelming revenue, below-average operating margin, and projected decline in free cash flow margin.
NFLX · Capital · Positive StockStory recommends buying Netflix citing strong membership growth, high EPS growth, and expanding free cash flow margin.
UHS · Capital · Negative StockStory recommends selling Universal Health Services due to weak comparable store sales and lack of free cash flow generation.
Universal Health Services Leads Hospital Chains in Q1 with Strong Revenue Growth
Universal Health Services reported first-quarter revenues of $4.50 billion, up 9.6% year on year and exceeding analyst expectations by 2.4%, making it the best performer among the four hospital chains tracked. The group overall posted mixed results, with aggregate revenues beating consensus estimates by 0.7% but next-quarter revenue guidance coming in 2.7% below expectations. Tenet Healthcare's revenue of $5.37 billion met estimates, while Acadia Healthcare's $828.8 million exceeded by 0.6% and HCA Healthcare's $19.11 billion matched expectations. Despite the beats, share prices across the group have fallen an average of 9% since reporting, with Universal Health Services down 18.7% and HCA Healthcare down 17.5%.
Zacks Highlights Tenet Healthcare, Universal Health Services, Acadia Healthcare, and Community Health Systems as Hospital Stocks to Watch
Zacks Equity Research identifies Tenet Healthcare, Universal Health Services, Acadia Healthcare, and Community Health Systems as hospital stocks worth watching amid a structural shift toward lower-cost care settings. The Zacks Medical-Hospital industry is seeing the fastest growth in ambulatory surgery centers, home health, and post-acute care, while hospitals face elevated costs and reimbursement uncertainty. The industry carries a Zacks Industry Rank of 107, placing it in the top 43% of nearly 250 industries, and its 2026 earnings estimates have risen 5.7% over the past year. Tenet Healthcare is expanding its ambulatory care segment, with consensus 2026 earnings per share of $17.61, up 5% year over year. Universal Health Services is growing through tuck-in acquisitions and facility expansion, with 2026 earnings per share estimated at $23.47, an 8% increase. Acadia Healthcare is seeing rising patient days and strong demand for mental health treatment, with 2026 earnings per share of $1.50 and a projected 14.8% jump in 2027. Community Health Systems is benefiting from lower expenses and improving payer mix, with 2026 revenues pegged at $11.56 billion and shares up 15.9% in the past month.
StockStory Flags MasterCraft, Cushman & Wakefield, and Universal Health Services as Value Stocks with Poor Fundamentals
StockStory has identified three value stocks with concerning fundamentals. MasterCraft, trading at 12.5 times forward earnings, saw revenue decline 6.7% annually over five years and has a low free cash flow margin of 7%. Cushman & Wakefield, at 8.7 times forward earnings, posted annual revenue growth of just 6% and lacks free cash flow generation. Universal Health Services, at 5.9 times forward earnings, faces lagging comparable store sales and a weak free cash flow margin of 4.2% over five years.
UBS says hospitals may gain more from AI than health insurers
UBS analysts say hospitals could build a more durable competitive advantage from artificial intelligence than health insurers, even as AI becomes a core operating layer across healthcare. Analyst A.J. Rice notes that while managed-care companies like UnitedHealth Group, Elevance Health, Humana, Cigna, and Centene are deploying AI for claims processing, prior authorization, and customer service, those efficiency gains are highly replicable and likely to be competed away through pricing or benefit enhancements. In contrast, large for-profit hospital operators such as HCA Healthcare, Tenet Healthcare, and Universal Health Services are using AI for revenue cycle management, denial appeals, and staffing optimization, and may maintain a multiyear lead over slower-moving nonprofit systems. UBS highlights that Universal Health Services generated approximately $50 million in annualized additional revenue from an AI coding platform, while HCA is using AI to fight claim denials and optimize nurse staffing with a Palantir-built platform. The report concludes that AI will improve profitability unevenly, with hospitals better positioned to retain gains and expand margins over time.
Artificial Intelligence › AI Applications & Copilots ▲Competition
HCA · Technology · Positive UBS highlights HCA's AI use for claim denials and nurse staffing, suggesting durable competitive advantage and margin gains.
UHS · Technology · Positive UBS highlights Universal Health Services' $50M annualized revenue from AI coding platform.
THC · Technology · Positive UBS says hospitals like Tenet may build durable AI advantage, improving profitability.
CI · Competition · Negative UBS says insurers' AI efficiency gains are replicable and will be competed away, limiting margin expansion.
CNC · Competition · Negative UBS says insurers' AI efficiency gains are replicable and will be competed away, limiting margin expansion.
ELV · Competition · Negative UBS says insurers' AI efficiency gains are replicable and will be competed away, limiting margin expansion.
USA